Healthcare Nanotechnology (Nanomedicine)

Healthcare Nanotechnology (Nanomedicine)

Global Healthcare Nanotechnology (Nanomedicine) Market to Reach $475.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Nanotechnology (Nanomedicine) estimated at US$183.9 Billion in the year 2020, is projected to reach a revised size of US$475.2 Billion by 2027, growing at a CAGR of 14.5% over the analysis period 2020-2027. Therapeutics, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$369.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Regenerative medicine segment is readjusted to a revised 15.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $54.3 Billion, While China is Forecast to Grow at 14% CAGR

The Healthcare Nanotechnology (Nanomedicine) market in the U.S. is estimated at US$54.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$82.8 Billion by the year 2027 trailing a CAGR of 14% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

In-vitro diagnostics Segment to Record 16.3% CAGR

In the global In-vitro diagnostics segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.7 Billion in the year 2020 will reach a projected size of US$16.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$56.9 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 190-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Celgene Corporation
  • CombiMatrix Corporation
  • GE Healthcare
  • Johnson & Johnson
  • Leadiant Biosciences, Inc.
  • Mallinckrodt PLC
  • Merck & Co., Inc.
  • NanoSphere Health Sciences, Inc.
  • Pfizer, Inc.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Healthcare Nanotechnology (Nanomedicine) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Healthcare Nanotechnology (Nanomedicine) Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Healthcare Nanotechnology (Nanomedicine) Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Healthcare Nanotechnology (Nanomedicine) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Therapeutics (Product Segment) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Therapeutics (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Therapeutics (Product Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Regenerative medicine (Product Segment) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Regenerative medicine (Product Segment) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Regenerative medicine (Product Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: In-vitro diagnostics (Product Segment) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: In-vitro diagnostics (Product Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: In-vitro diagnostics (Product Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: In-vivo diagnostics (Product Segment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: In-vivo diagnostics (Product Segment) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: In-vivo diagnostics (Product Segment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Vaccines (Product Segment) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 17: Vaccines (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 18: Vaccines (Product Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Anticancer (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 20: Anticancer (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: Anticancer (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
TABLE 22: CNS Product (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
TABLE 23: CNS Product (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 24: CNS Product (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Anti-infective (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
TABLE 26: Anti-infective (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
TABLE 27: Anti-infective (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
TABLE 28: Other Applications (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 29: Other Applications (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
TABLE 30: Other Applications (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Healthcare Nanotechnology (Nanomedicine) Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 31: United States Healthcare Nanotechnology (Nanomedicine) Market Estimates and Projections in US$ Million by Product Segment: 2020 to 2027
TABLE 32: Healthcare Nanotechnology (Nanomedicine) Market in the United States by Product Segment: A Historic Review in US$ Million for 2012-2019
TABLE 33: United States Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 34: United States Healthcare Nanotechnology (Nanomedicine) Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
TABLE 35: Healthcare Nanotechnology (Nanomedicine) Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
TABLE 36: Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
TABLE 37: Canadian Healthcare Nanotechnology (Nanomedicine) Market Estimates and Forecasts in US$ Million by Product Segment: 2020 to 2027
TABLE 38: Canadian Healthcare Nanotechnology (Nanomedicine) Historic Market Review by Product Segment in US$ Million: 2012-2019
TABLE 39: Healthcare Nanotechnology (Nanomedicine) Market in Canada: Percentage Share Breakdown of Sales by Product Segment for 2012, 2020, and 2027
TABLE 40: Canadian Healthcare Nanotechnology (Nanomedicine) Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 41: Healthcare Nanotechnology (Nanomedicine) Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 42: Canadian Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
TABLE 43: Japanese Market for Healthcare Nanotechnology (Nanomedicine): Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2020-2027
TABLE 44: Healthcare Nanotechnology (Nanomedicine) Market in Japan: Historic Sales Analysis in US$ Million by Product Segment for the Period 2012-2019
TABLE 45: Japanese Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 46: Japanese Demand Estimates and Forecasts for Healthcare Nanotechnology (Nanomedicine) in US$ Million by Application: 2020 to 2027
TABLE 47: Japanese Healthcare Nanotechnology (Nanomedicine) Market in US$ Million by Application: 2012-2019
TABLE 48: Healthcare Nanotechnology (Nanomedicine) Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
TABLE 49: Chinese Healthcare Nanotechnology (Nanomedicine) Market Growth Prospects in US$ Million by Product Segment for the Period 2020-2027
TABLE 50: Healthcare Nanotechnology (Nanomedicine) Historic Market Analysis in China in US$ Million by Product Segment: 2012-2019
TABLE 51: Chinese Healthcare Nanotechnology (Nanomedicine) Market by Product Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 52: Chinese Demand for Healthcare Nanotechnology (Nanomedicine) in US$ Million by Application: 2020 to 2027
TABLE 53: Healthcare Nanotechnology (Nanomedicine) Market Review in China in US$ Million by Application: 2012-2019
TABLE 54: Chinese Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Healthcare Nanotechnology (Nanomedicine) Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 55: European Healthcare Nanotechnology (Nanomedicine) Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 56: Healthcare Nanotechnology (Nanomedicine) Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 57: European Healthcare Nanotechnology (Nanomedicine) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 58: European Healthcare Nanotechnology (Nanomedicine) Market Estimates and Forecasts in US$ Million by Product Segment: 2020-2027
TABLE 59: Healthcare Nanotechnology (Nanomedicine) Market in Europe in US$ Million by Product Segment: A Historic Review for the Period 2012-2019
TABLE 60: European Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 61: European Healthcare Nanotechnology (Nanomedicine) Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 62: Healthcare Nanotechnology (Nanomedicine) Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 63: European Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
TABLE 64: Healthcare Nanotechnology (Nanomedicine) Market in France by Product Segment: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 65: French Healthcare Nanotechnology (Nanomedicine) Historic Market Scenario in US$ Million by Product Segment: 2012-2019
TABLE 66: French Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 67: Healthcare Nanotechnology (Nanomedicine) Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
TABLE 68: French Healthcare Nanotechnology (Nanomedicine) Historic Market Review in US$ Million by Application: 2012-2019
TABLE 69: French Healthcare Nanotechnology (Nanomedicine) Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
TABLE 70: Healthcare Nanotechnology (Nanomedicine) Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2020-2027
TABLE 71: German Healthcare Nanotechnology (Nanomedicine) Historic Market Analysis in US$ Million by Product Segment: 2012-2019
TABLE 72: German Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 73: Healthcare Nanotechnology (Nanomedicine) Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
TABLE 74: German Healthcare Nanotechnology (Nanomedicine) Market in Retrospect in US$ Million by Application: 2012-2019
TABLE 75: Healthcare Nanotechnology (Nanomedicine) Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
TABLE 76: Italian Healthcare Nanotechnology (Nanomedicine) Market Growth Prospects in US$ Million by Product Segment for the Period 2020-2027
TABLE 77: Healthcare Nanotechnology (Nanomedicine) Historic Market Analysis in Italy in US$ Million by Product Segment: 2012-2019
TABLE 78: Italian Healthcare Nanotechnology (Nanomedicine) Market by Product Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 79: Italian Demand for Healthcare Nanotechnology (Nanomedicine) in US$ Million by Application: 2020 to 2027
TABLE 80: Healthcare Nanotechnology (Nanomedicine) Market Review in Italy in US$ Million by Application: 2012-2019
TABLE 81: Italian Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 82: United Kingdom Market for Healthcare Nanotechnology (Nanomedicine): Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2020-2027
TABLE 83: Healthcare Nanotechnology (Nanomedicine) Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Segment for the Period 2012-2019
TABLE 84: United Kingdom Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 85: United Kingdom Demand Estimates and Forecasts for Healthcare Nanotechnology (Nanomedicine) in US$ Million by Application: 2020 to 2027
TABLE 86: United Kingdom Healthcare Nanotechnology (Nanomedicine) Market in US$ Million by Application: 2012-2019
TABLE 87: Healthcare Nanotechnology (Nanomedicine) Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 88: Rest of Europe Healthcare Nanotechnology (Nanomedicine) Market Estimates and Forecasts in US$ Million by Product Segment: 2020-2027
TABLE 89: Healthcare Nanotechnology (Nanomedicine) Market in Rest of Europe in US$ Million by Product Segment: A Historic Review for the Period 2012-2019
TABLE 90: Rest of Europe Healthcare Nanotechnology (Nanomedicine) Market Share Breakdown by Product Segment: 2012 VS 2020 VS 2027
TABLE 91: Rest of Europe Healthcare Nanotechnology (Nanomedicine) Addressable Market Opportunity in US$ Million by Application: 2020-2027
TABLE 92: Healthcare Nanotechnology (Nanomedicine) Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
TABLE 93: Rest of Europe Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 94: Healthcare Nanotechnology (Nanomedicine) Market in Asia-Pacific by Product Segment: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 95: Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Historic Market Scenario in US$ Million by Product Segment: 2012-2019
TABLE 96: Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Product Segment: 2012 VS 2020 VS 2027
TABLE 97: Healthcare Nanotechnology (Nanomedicine) Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
TABLE 98: Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Historic Market Review in US$ Million by Application: 2012-2019
TABLE 99: Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Share Analysis: A 17-Year Perspectiveby Application for 2012, 2020, and 2027
REST OF WORLD
TABLE 100: Rest of World Healthcare Nanotechnology (Nanomedicine) Market Estimates and Forecasts in US$ Million by Product Segment: 2020 to 2027
TABLE 101: Rest of World Healthcare Nanotechnology (Nanomedicine) Historic Market Review by Product Segment in US$ Million: 2012-2019
TABLE 102: Healthcare Nanotechnology (Nanomedicine) Market in Rest of World: Percentage Share Breakdown of Sales by Product Segment for 2012, 2020, and 2027
TABLE 103: Rest of World Healthcare Nanotechnology (Nanomedicine) Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
TABLE 104: Healthcare Nanotechnology (Nanomedicine) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
TABLE 105: Rest of World Healthcare Nanotechnology (Nanomedicine) Market Share Analysis by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 46

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook